# Editorial: Perspectives on new fast-acting antidepressants

**Authors:** Rodrigo Simonini Delfino, Balwinder Singh, Acioly L. T. Lacerda

PMC · DOI: 10.3389/fpsyt.2024.1430990 · Frontiers in Psychiatry · 2024-05-27

## Full-text entities

- **Genes:** BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}
- **Diseases:** inflammatory (MESH:D007249), Major Depressive Disorder (MESH:D003865), hypertension (MESH:D006973), Depression (MESH:D003866), bipolar depression (MESH:D001714), neuropsychiatric syndrome (MESH:C000631768), RD (MESH:D000077733), anxiety (MESH:D001007), RAADs (MESH:C564983), suicidal ideation and (MESH:D001072), psychiatric disorders (MESH:D001523), lung cancer (MESH:D008175), Catatonia (MESH:D002389)
- **Chemicals:** esketamine (MESH:C000629870), brexanolone (MESH:C000625635), psilocybin (MESH:D011562), dextromethorphan (MESH:D003915), N-methyl-D-aspartate (MESH:D016202), zuranolone (MESH:C000634505), scopolamine (MESH:D012601), -acting antidepressants (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11163094/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC11163094/full.md

---
Source: https://tomesphere.com/paper/PMC11163094